A B S T R A C T The effect of methylprednisolone (2 ing/kg per day given parenterally for 3 doses, 2 wk or 12 wk) on the permeability of mammalian gastric mucosa to hydrogen ion (H+) was examined with denervated fundic pouches in dogs with antrectomies. Transmucosal electric potential difference (PD) and net fluxes of H+ and Na+ were determined for luminal [H+] from 20 to 160 mM and [Na+] from 1 to 140 mM ([H+] and [Na+] were varied reciprocally). The PD was 50-60 mV lumen negative and was constant over the entire range of Na+ and H+ concentration tested. Net H+ flux varied linearly with [H+]. Extrapolation indicated apparent H+ loss at zero luminal concentration, suggesting a basal HCO3-secretion. Addition of acetylsalicylic acid (ASA) or taurocholate decreased the PD to 30-40 mV and increased threefold the slope of the relation between net H+ flux and [H+] (kH). Calculation of PDindependent permeability constants for H+ (PH) with the Goldman constant field equation indicated that this increase in kH could not be attributed solely to the associated decrease in PD. Prednisolone administered for 3 doses had no effect on either the basal mucosal permeability to H+ or the altered permeability induced by ASA or taurocholate. Chronic administration induced a low rate of basal acid secretion (at 12 wk) but had no effect on either PD or kH. However, the increase in kH and PH that developed upon addition of ASA or taurocholate in chronically treated dogs was more than one and a half times that of controls. These data suggest that prolonged treatPart of this work was presented at
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INTRODUCTION
Ingle reported over 30 years ago that administration of large doses of glucocorticoids to rats resulted in a high incidence of gastric ulceration (1, 2) . For years it was held that glucocorticoids were potentially ulcerogenic, but recent reviews of randomized, double-blind trials provide no support for this contention (3, 4) . As Conn and Blitzer (4) point out however, the lack of proof for an association between glucocorticoids and peptic ulcers does not summarily exclude a role for steroids in ulcerogenesis because in controlled trials an increased incidence of peptic ulcers was observed in patients with nephrotic syndrome (5) or cirrhosis (6) who received glucocorticoids, or in other patients receiving a total dose which exceeded 1,000 mg. It has been suggested that the reduced serum binding capacity resulting from the hypoalbuminemia in nephrosis and cirrhosis may lead to high blood levels of unbound steroids. Prospective clinical studies may never conclusively settle the issue because a very large number of patients suffering from conditions marginally benefited by steroid would be required for such a trial (4) .
Laboratory studies of the effects of glucocorticoids on gastric secretion have produced conflicting results. Chronic glucocorticoid administration to animals with intact adrenals has no effect on gastric secretion in the rat (7), increases acid and pepsin secretion in the dog (8) , and produces equivocal findings in man (7) . Whether chronic administration of glucocorticoids affects the rate of H+ reabsorption from the stomach is not known. Cooke et al. (9) measured gastric absorption of H+ at a single luminal concentration and showed no significant alteration in the rate of H+ absorption in denervated fundic pouches in adrenalectomized dogs treated for 1 mo with desoxycorticosterone alone, desoxycorticosterone plus hydrocortisone, or just supplemental intake of sodium chloride. Chvasta and Cooke (10) later showed that topical instillation of hydrocortisone or cortisone acetate also had no effect on the net H+ or electrolyte fluxes or the potential difference across the canine gastric mucosa. In view of the postulated role of increased permeability of the gastric mucosa to H+ as a mechanism for gastric mucosal injury, we further studied in dogs the effects of acute and chronic administration of high doses of methylprednisolone either alone or in combination with acetylsalicylic acid (ASA)1 or taurocholate on the permeability of the gastric mucosa to HW.
METHODS
Antrectomy and denervated fundic pouches were prepared in 20 beagle dogs weighing 13-16 kg as previously described (11) . 6 wk after operation the animals were feeding well and had maintained a stable weight. Food but not water was withheld for 18 h before each study. The fundic pouch, equipped with a Thomas cannula, was perfused with electrolyte solution in a recirculating circuit at 37°C at a hydrostatic pressure of less than 5 cm H20 as described previously (11) . Four sets of solutions of graded H+ concentrations (20, 40, 80, 120 , and 160 mM) were employed. One set contained 10 mM ASA in each of the solutions, the second set contained 20 mM ASA, the third set contained 20 mM Na taurocholate, and the fourth contained HCl alone. Except for the 160 mM solution, all were brought to 300+2 mosmol per kg H20 with NaCl. They also contained polyethylene glycol (PEG, Carbowax 4000, Union Carbide Corp., New York), 10 g per liter, and [14C]PEG 100 mg per liter (sp act 0.4 ,uCi per mg, New England Nuclear, Boston, Mass.) as a volume marker. The osmolality of the solutions containing 160 mM of HI and either ASA or taurocholate was 330±2 mosmol per kg H20. To begin the experiment, 50 ml of solution was pipetted into the reservoir and circulated by a roller pump. 5-ml samples were taken half hourly. In about two-thirds of the experiments, including all the ASA and taurocholate experiments, the solutions remained in the pouch for 60 min, whereas the rest had 90 min of perfusion for each solution. At each change of solutions, the pouch was emptied and was rinsed with a solution identical in composition to the solution to be instilled next except that it contained no [14C]PEG. 10 min were allowed for complete drainage. All drainage and rinsings from the pouch were collected and measured to 0.1 ml and assayed for 14C for calculation of PEG recovery. Not more than three test solutions were instilled on the same day. The sequence of instillation was randomized with respect to ascending or descending order of HI concentrations. The resting character of the pouch (i.e., absence of HI secretion in the basal state) was established in all I Abbreviations used in this paper: ASA, acetylsalicylic acid; ASAH, undissociated form of acetylsalicylic acid; kH, concentration-independent coefficient for HI loss from the gastric lumen; PD, transmucosal electric potential difference; PEG, polyethylene glycol; PH, PD-independent permeability constant for H+. dogs at 6 wk after operation before commencement of the main study. These preliminary tests were carried out with instillation of 50 ml of a solution of 300 mM NaCl containing volume marker, with 1-ml samples taken at 30-min intervals for detection of any net H+ secretion.
The samples were analyzed for H+ by titrating 1-mi aliquots with 0.1 NaOH to pH 7.00 with an automatic titrimeter (Radiometer Co., Copenhagen, Denmark). Sodium was determined by flame photometry (Instrumentation Laboratories, Inc., Lexington, Mass.). Duplicate aliquots of 1 ml were pipetted into albumin-coated planchets, dried under an infrared lamp, and counted in a gas-filled, low-background planchet counting chamiiber (model 1943, Nuclear-Chicago Corp., Des Plaines, Ill.). In -two-thirds of the experiments, ['4C]PEG was determined by counting duplicates of aliquots of 500 ull in a liquid scintillation counter (Beckman Instruments, Inc., Fullerton, Calif., LS-230) connected to on-line computer until the variability was 0.2%. Reproducibility of both methods was the same and was sufficient to detect a volume change of 0.1-0.2 ml. The PEG recoveries for over 100 experiments were 99.2+1. The signs of net flux measurement indicate movement into (+) or out of (-) the gastric lumen.
Gastric absorption of ASA (14 dogs) and sodium taurocholate (2 dogs) was determined by measuring the concentration of these substances in the samples of perfusate. Salicylate was determined by a colorimeteric method employing a ferric salt as reagent as modified by Trinder (12) , and sodium taurocholate was determined by a dehydrogenase method according to Talalay (13) .
Permeability characteristics of the gastric mucosa to hydrogen were evaluated by plotting net H+ fluxes in ,umol/30 min against the average luminal H+ concentration for each 30-min flux period. The resulting relationships were characterized by simple linear regression analysis and the slopes were compared by analysis of covariance (14) . Four sets of initial studies (namely, base-line, 10 mM ASA, 20 mM ASA, and taurocholate) were completed. Methyprednisolone sodium succinate (Solu-Medrol, Upjohn Co., Kalamazoo, Mich.) was then given by intramuscular route in three different schedules, each to one group of dogs. For singledose experiments, an i.m. injection of methylprednisolone at 2 mg/kg was given to 4 dogs 16 h before each of the following studies conducted in sequence: ASA (20 mnM), basal, taurocholate, taking 2 days for each study. These dogs thus received a total of 3 doses over a 6-day period.
In the second treatnment schedule, methylprednisolone was given intramuscularly at 2 mg/kg for 19 days to 4 other dogs.
Beginning on the 14th day, ASA (20 mM), basal, and taurocholate studies were repeated in that order. In the third treatment schedule, another three dogs received a depot form of the steroid methylprednisolone acetate (Depo-Medrol, Upjohn Co.) at 7 mg/kg by weekly i.m. injections for 13
wk. This dose corresponds to 1 mg/kg per day of methylprednisolone sodium succinate. The ASA studies were repeated beginning 12 wk after treatment. The conitrol aniGastric Absorption of Hydrogen Ion mals, given intramuscular saline injections for 1 dose (two dogs), 2 wk (four dogs), and 12 wk (three dogs), were similarly tested on an identical schedule. Serum electrolytes measured before and after treatment period remained unchanged in both prednisolone-treated and control animals. No apparent ill effects were observed in the animals during the treatment period.
Transmucosal electric potential difference (PD) was measured as previously described (11) . The PD probes (3-M KCI bridges) were placed in the gastric lumen and a cephalic vein. Junctional PD between Ringer's solution and various test solutions were determined with the same bridges and measuring instruments, and was found never to exceed 0.5 mV.
Gastric mucosal biopsies ofthe pouches performed through the Thomas cannula in the control and prednisolone-treated (both long and short terms) dogs showed no detectable differences or abnormality on light microscopy. Nor was there any readily detectable difference between biopsies obtained 6 wk after operation and 4 mo after operation in the control animals.
RESULTS
Effect of prednisolone on basal acid secretion in the denervated pouch. None of the dogs showed any secretion in the basal fasting state when tested 6 wk to 3 mo after operation. This remained unchanged when retested after treatment with prednisolone for 1 dose or for 2 wk. However, dogs treated with prednisolone for 12 wk showed a basal secretion of 34±+11 ,mol/30 min (n = 6) at the end of the treatment period, significantly different from before treatment (P < 0.01).
Effect of luminal H+ concentration on net H+ flux under base-line conditions and in the presence ofASA and taurocholate. As illustrated in Fig. 1 , a linear relationship was obtained when net H+ fluxes were plotted against [H+] . The slope of this line provides a concentration-independent coefficient for H+ loss from the gastric lumen (kH). Values of kH were not corrected for the surface area of each fundic pouch because each dog served as his own control and because pouches in all dogs were of approximately the same size, holding 35-37 ml of solution in the nondistended state. Mean values for kH, correlation coefficient, and y-intercept for 14 dogs under base-line conditions are listed in Table I , and all individual data are included in Fig. 1 . The negative y-intercept, which indicates apparent net loss of H+ in the absence of luminal H+, suggests that some HCO3-(or OH-) is secreted under base-line conditions. This observation has also been made by others (15) (16) (17) .
Addition of either ASA (20 mM) or taurocholate (20 mM) to the perfusate produced a threefold increase in kH whereas the relation between net H+ flux and [H+] remained linear (see Fig. 1 and Table I ). Addition of 10 mM ASA produced a smaller increase in kH with no effect on the linearity of the JH/[H+] plot (Table I ). The mean y-intercepts were negative in all experiments, suggesting HCO3-secretion or absorption of ASAH or taurocholic acid (see Discussion). However, the magnitude of the intercepts was not significantly different from that measured under base-line conditions. The smaller increase in kH seen with 10 mM ASA was associated with smaller methylprednisolone did not affect the change in kH induced by ASA or taurocholate (Table II) . However, both ASA and taurocholate produced significantly greater increases in kH after 2 wk of prednisolone treatment than before treatment (each dog compared to itself; P < 0.001). Also, dogs given 2 wk of prednisolone showed a greater kH when challenged with ASA or taurocholate than dogs given saline (Table III, Figs. 2 and 3) (P < 0.01). Table IV compares the changes in kH produced by ASA in three dogs which received depot prednisolone (Depo-Medrol) at 7 mg/kg per wk for 12-13 wk, with the findings in three dogs which received saline injections. Significantly greater kH values were again observed in the prednisolone-treated group (P < 0.01). A positive y-intercept was found in the group of dogs subjected to 12 wk of prednisolone injections (Fig. 4) . This was significantly different from zero and from the saline-injected controls (P < 0.01). ASA-induced kH's after 12 wk of prednisolone were significantly greater than before treatment (each dog compared to itself; P < 0.001). Comparison of the results of the two chronic prednisolone treatment schedules showed that ASA produced similar kH's in both groups but the y-intercept was greater (positive) in the group treated for a longer duration (P < 0.01). The new intercept, both in the direction and mnagnitude, is compatible with our findings in the base-line secretory studies in which long-term prednisolone treatment resulted in a small increase in base-line acid secretion. Table VI ). Taurocholate absorption was small, however, compared to overall H+ absorption. The measured rate of taurocholate absorption varied from 13% of the net H+ flux at 20 mM [H+] to 8.6% of the net H+ flux at 160 mM [H+] . Thus, the loss of linearity because of nonionic diffusion of taurocholic acid was less than 5%, which may not be seen on the plots because of experimental variations. However, the increase in kH from increased absorption of taurocholate may well have made the graphs curvilinear, although this was not borne out from our data. It is not known how much of an increase in kH would be caused by the demonstrated increase of taurocholate absorption at lower pH.
Neither 1 dose nor 2 wk of treatment with prednisolone induced basal acid secretion from the fundic pouch, but 12 wk of treatment did. The mechanism of this increase is unknown, but increase in basal acid secretion has also been reported in in vivo, canine, gastric secretory studies in the literature (8, 9) . A single in vitro study of the mammalian gastric mucosa also demonstrated a marginally increased acid secretion in addition to increased ionic conductance when the mucosa was exposed to desoxycorticosterone (25) .
Although administration of prednisolone did not by itself increase the ionic permeability, it did potentiate the action of ASA and taurocholate. The potentiation was as great after 2 wk of treatment as after 3 mo of treatment. As increased permeability induced by ASA (Table I) and bile salts (26) appeared to be related to the amount absorbed, the potentiation effect of glucocorticoid could have been explained by increased absorption of ASA or taurocholate. However, our data indicate that prednisolone had no effect on absorption of either agent thereby excluding this possibility as the explanation for the observed potentiation. Thus glucocorticoids may truly Gastric Absorption of Hydrogen Ionincrease the susceptibility of the gastric mucosa to damage by other agents. A possible explanation for the present physiologic observations is suggested by studies of the effects of ACTH and glucocorticoids on the rate of cell renewal in the gastric mucosa. Rasanen reported that administration of glucocorticoids to the rat resulted in a decrease in the frequency of mitotic figures in the gastric mucosa (27, 28) . Loeb and Sternschein found that the administration of cortisone markedly suppressed thymidine incorporation into DNA in the gastric mucosa of young rats within 24 h (29). Max and Menguy (30) showed that after 2-4 wk of treatment with ACTH, adult dogs displayed a reduction in the mitotic index in the gastric mucosa and also a reduction in the rate of exfoliation of the mucosal cells. A steroid-induced reduction in the rate of turnover of gastric mucosal cells increases the average age of these cells. It is conceivable that the older cells are more readily damaged (or caused to exfoliate) by ASA and taurocholate than are younger cells.
